Area of research
Computer Vision and Pattern Recognition · Surgery
Research interest
Research focused on Myocardial infarction and Varenicline, with related work in Randomized controlled trial, Angiology, SNi. Notable publications include 'Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial', 'GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial', and 'Fractal frontiers in cardiovascular magnetic resonance: towards clinical implementation'.
Effects of transcranial alternating current stimulation on measures of cognition and symptom scores in Chinese patients with schizophrenia
Multiscale interstitial fluid computation modeling of cortical bone to characterize the hydromechanical stimulation of lacunar-canalicular network
Short-Term Risk Stratification of Non–Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain
The Association Between Angiographically Derived Radial Wall Strain and the Risk of Acute Myocardial Infarction
Lidocaine Alleviates Neuropathic Pain and Neuroinflammation by Inhibiting HMGB1 Expression to Mediate MIP-1α/CCR1 Pathway
Metabolic phenotyping to monitor chronic enteritis canceration
Phase modulation of bcc-structured Fe35Mn25Al15Cr10Ni15 high-entropy alloy by interstitial carbon
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Karyopherin α2 induces apoptosis in tongue squamous cell carcinoma CAL-27 cells through the p53 pathway
Fractal frontiers in cardiovascular magnetic resonance: towards clinical implementation
Vascular endothelial growth factor expression and pathological changes in the local tissue of facial hemangiomas following injections with pure alcohol
Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
Repair of mandibular defects by bone marrow stromal cells expressing the basic fibroblast growth factor transgene combined with multi-pore mineralized Bio-Oss
Biological characteristics of colorectal adenoma with chicken-skin mucosa and its clinical significance